Cargando…

High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients

BACKGROUND: Cellular immunodeficiency and comorbidities are common in COVID-19 patients. AIM: The purpose of this study was to investigate comorbidities impacting on the cellular immunity in COVID-19 patients. METHODS: The research objects included 55 healthy controls and 718 COVID-19 patients who d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dafeng, Yuan, Xiaoyan, Gao, Fengjiao, Zhao, Bennan, Ding, Ling, Huan, Mingchang, Liu, Chao, Jiang, Liangshuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295452/ https://www.ncbi.nlm.nih.gov/pubmed/35865540 http://dx.doi.org/10.3389/fimmu.2022.899930

Ejemplares similares

How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study
por: Wang, Yiting, et al.
Publicado: (2023)

Nutritional risk and a high NRS2002 score are closely related to disease progression and poor prognosis in patients with COVID-19
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China
por: Xu, Renjie, et al.
Publicado: (2022)

Immunity: Psoriasis comorbid with atherosclerosis
por: Liu, Chunping, et al.
Publicado: (2022)

Two Cases of COVID-19 with Persistently Positive SARS-CoV-2-Specific IgM During One-Year Follow-Up — Sichuan Province, China, February 2021
por: Zhao, Bennan, et al.
Publicado: (2021)

Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19
por: Liu, Dafeng, et al.
Publicado: (2022)

Could β-Lactam Antibiotics Block Humoral Immunity?
por: Melenotte, Cléa, et al.
Publicado: (2021)

Immunomodulation resulting of helminth infection could be an opportunity for immunization against tuberculosis and mucosal pathogens
por: Chin, Kai Ling, et al.
Publicado: (2023)

Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus
por: Liu, Dafeng, et al.
Publicado: (2020)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8(+) T Cells
por: Zhou, Xiu-Man, et al.
Publicado: (2018)

Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
por: Geller, Anne, et al.
Publicado: (2020)

Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022)

Augmented Innate and Adaptive Immune Responses Under Conditions of Diabetes–Filariasis Comorbidity
por: Sibi, Joy Manohar, et al.
Publicado: (2021)

Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review
por: Bu, Jin, et al.
Publicado: (2022)

miRNA-124 in Immune System and Immune Disorders
por: Qin, Zhen, et al.
Publicado: (2016)

Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer
por: Li, Chao, et al.
Publicado: (2023)

Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
por: Abid, Muhammad Abbas, et al.
Publicado: (2020)

The Immune Barrier of Porcine Uterine Mucosa Differs Dramatically at Proliferative and Secretory Phases and Could Be Positively Modulated by Colonizing Microbiota
por: Han, Deping, et al.
Publicado: (2021)

Effect of D-Ala-Ended Peptidoglycan Precursors on the Immune Regulation of Lactobacillus plantarum Strains
por: Song, Xin, et al.
Publicado: (2022)

Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis
por: Liu, Lu, et al.
Publicado: (2022)

Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
por: Flynn, Jacqueline K., et al.
Publicado: (2019)

Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus
por: Liu, Dafeng, et al.
Publicado: (2021)

Follow-Up Study of the Cardiopulmonary and Psychological Outcomes of COVID-19 Survivors Six Months After Discharge in Sichuan, China
por: Dai, Shuiping, et al.
Publicado: (2021)

Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein
por: Zhang, Yunwen, et al.
Publicado: (2022)

Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease
por: Jiang, Ziqi, et al.
Publicado: (2023)

Oral exposure to Staphylococcus aureus enterotoxin B could promote the Ovalbumin-induced food allergy by enhancing the activation of DCs and T cells
por: Yuan, Jin, et al.
Publicado: (2023)

Hepatopancreas-Specific Lectin Participates in the Antibacterial Immune Response by Regulating the Expression of Antibacterial Proteins
por: Cao, Xiao-Tong, et al.
Publicado: (2021)

Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy
por: Chanzu, Nadia, et al.
Publicado: (2014)

Pregnancy Induces an Immunological Memory Characterized by Maternal Immune Alterations Through Specific Genes Methylation
por: Huang, Xiaobo, et al.
Publicado: (2021)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023)

Alarmins, COVID-19 and comorbidities
por: Di Salvo, Eleonora, et al.
Publicado: (2021)

EST12 regulates Myc expression and enhances anti-mycobacterial inflammatory response via RACK1-JNK-AP1-Myc immune pathway
por: Wu, Jian, et al.
Publicado: (2022)

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022)

Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With Mycobacterium tuberculosis
por: Basile, Juan I., et al.
Publicado: (2020)

PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology
por: Chen, Zheng, et al.
Publicado: (2021)

An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
por: McLean, Milla R., et al.
Publicado: (2019)

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
por: Meini, Simone, et al.
Publicado: (2020)

MAOI Antidepressants: Could They Be a Next-Generation ICB Therapy?
por: Brown, James, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufhh9nu45g6itershpc196adh6